Vertex Pharmaceuticals (VRTX) Treasury Shares (2010 - 2025)
Vertex Pharmaceuticals (VRTX) posted quarterly Treasury Shares of $2.5 million for Q4 2025, down 5.28% year-over-year from $2.7 million in Q4 2024, and down 5.28% quarter-over-quarter from $2.7 million in Q4 2024.
Vertex Pharmaceuticals (VRTX) Treasury Shares (2010 - 2025) Analysis & Trends
Vertex Pharmaceuticals' Treasury Shares history runs 16 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- In Q4 2025, Treasury Shares fell 5.28% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (down 5.28% YoY), while the FY2025 annual figure was $2.5 million, down 5.28% from the prior year.
- Treasury Shares for Q4 2025 stood at $2.5 million, down from $2.7 million in the prior quarter.
- The five-year high for Treasury Shares was $3.0 million in Q4 2023, with the low at $2.5 million in Q4 2025.
- The 5-year median for Treasury Shares is $2.9 million (2021), against an average of $2.8 million.
- The sharpest annual moves came in 2021 and 2024: Treasury Shares increased 6.87% in 2021, then declined 9.25% in 2024.
- Vertex Pharmaceuticals' Treasury Shares stood at $2.9 million in 2021, then rose by 0.14% to $2.9 million in 2022, then climbed by 1.68% to $3.0 million in 2023, then decreased by 9.25% to $2.7 million in 2024, then fell by 5.28% to $2.5 million in 2025.
- Business Quant data shows VRTX's Treasury Shares at $2.5 million in Q4 2025, $2.7 million in Q4 2024, and $3.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 48.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.55 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.91 Mn |
| Dec 31, 2021 | 2.91 Mn |
| Dec 31, 2020 | 2.72 Mn |
| Dec 31, 2020 | 2.72 Mn |
| Dec 31, 2019 | 734,000.00 |
| Dec 31, 2019 | 734,000.00 |
| Sep 30, 2019 | 500.00 Mn |
| Sep 30, 2019 | 500.00 Mn |
| Jun 30, 2019 | 500.00 Mn |
| Jun 30, 2019 | 500.00 Mn |
| Mar 31, 2019 | 500.00 Mn |
| Mar 31, 2019 | 500.00 Mn |